SeaStar Medical Holding Corporation
ICU
$0.8891
$0.089111.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -55.89% | -25.26% | 6.84% | 17.95% | 32.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -55.15% | 4.18% | 54.11% | 53.77% | 24.51% |
| Operating Income | 62.39% | 3.24% | -51.97% | -51.46% | -24.51% |
| Income Before Tax | 38.08% | 70.32% | 53.30% | 38.08% | -32.39% |
| Income Tax Expenses | -- | -- | 100.00% | -- | -40.00% |
| Earnings from Continuing Operations | 38.13% | 70.29% | 53.27% | 38.08% | -32.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.13% | 70.29% | 53.27% | 38.08% | -32.24% |
| EBIT | 62.39% | 3.24% | -51.97% | -51.46% | -24.51% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 82.77% | 90.75% | 85.34% | 87.85% | 74.96% |
| Normalized Basic EPS | 82.76% | 90.76% | 85.65% | 61.51% | 74.93% |
| EPS Diluted | 82.77% | 90.75% | 85.34% | 87.85% | 74.96% |
| Normalized Diluted EPS | 82.76% | 90.76% | 85.65% | 61.51% | 74.93% |
| Average Basic Shares Outstanding | 259.12% | 221.06% | 218.69% | 409.65% | 428.18% |
| Average Diluted Shares Outstanding | 259.12% | 221.06% | 218.69% | 409.65% | 428.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |